Greifswald – 1st March 2021
CHEPLAPHARM is delighted to herewith inform of the change of its board of management.
With effect as of 1st of March 2021 Edeltraud Lafer, COO since 2014, will hand over her position to Patrick König, former Director Global Sales of CHEPLAPHARM. At the same time Edeltraud Lafer will take over the role as Co-CEO besides Sebastian Braun to manage the company in form of a dual leadership.
In this way, CHEPLAPHARM wants to clearly place its core competence, the business development, in the focus of the company's future business.